Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/19035362

Download in:

View as

General Info

PMID
19035362